Vanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024
Vanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024
The conference call will be broadcast simultaneously and archived on Vanda's website, . Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.Conference Call and Webcast to Follow
將會有電話會議和網絡直播。
WASHINGTON, July 26, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the second quarter 2024 on Wednesday, July 31, 2024, after the market closes.
2024年7月31日週三美國東部時間下市後，Vanda製藥公司（Vanda）（納斯達克股票代碼：VNDA）今天宣佈將發佈2024年第二季度業績。
Vanda will host a conference call at 4:30 PM ET on Wednesday, July 31, 2024, during which management will discuss the second quarter 2024 financial results and other corporate activities. To participate in the conference call, please dial 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and use passcode 1278669.
Vanda將於2024年7月31日（星期三）下午4點30分舉行電話會議，屆時管理層將討論2024年第二季度財務業績和其他公司活動。參加電話會議，請撥打1-800-715-9871（國內）或1-646-307-1963（國際），並使用密碼1278669。
The conference call will be broadcast simultaneously and archived on Vanda's website, . Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.
電話會議將同步播放並存檔在Vanda的網站上。投資者至少提前15分鐘登錄網站註冊，下載，並安裝所需的音頻軟件。
A replay of the call will be available on Wednesday, July 31, 2024, beginning at 8:30 PM ET and will be accessible until Wednesday, August 7, 2024, at 11:59 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 1278669.
回放將於2024年7月31日星期三下午8點30分開始，並將持續到2024年8月7日星期三晚上11點59分，可通過撥打國內聽衆的1-800-770-2030或國際聽衆的1-609-800-9909進行訪問。密碼是1278669。
About Vanda Pharmaceuticals Inc.
關於Vanda製藥公司。Vanda是一家領先的全球生物製藥公司，專注於開發和商業化創新療法以解決高度未滿足的醫療需求，並改善患者生活。欲了解更多有關Vanda製藥公司的信息，請訪問網站並關注我們的X @vandapharma。
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit and follow us on X @vandapharma.
Vanda是一家領先的全球生物製藥公司，專注於開發和商業化創新療法，以解決高度未滿足的醫療需求，並改善患者的生活。如需了解更多關於Vanda Pharmaceuticals Inc.的信息，請訪問並關注我們在X上的賬號@vandapharma。
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
[email protected]
公司聯繫人:
凱文·莫蘭
高級副總裁、首席財務官和財務總監
萬達製藥公司
202-734-3400
[email protected]
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
[email protected]
吉姆·高登/傑克·凱利赫爾/丹·摩爾
1-212-379-2072
[email protected]
SOURCE Vanda Pharmaceuticals Inc.
資料來源: Vanda Pharmaceuticals Inc.
